Evidence map›Paper›PMID 37786793›Full record

ReviewIbrain2021

Application value of molecular imaging technology in epilepsy.

Rong Yan, Hai-Qing Zhang, Jing Wang, Yong-Su Zheng, Zhong Luo, Xia Zhang, Zu-Cai Xu

Erratum issuedOpen access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Ibrain, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rong YanDepartment of Neurology The Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China.
Hai-Qing ZhangDepartment of Neurology The Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China.
Jing WangPrevention and Health Care, The Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China.
Yong-Su ZhengDepartment of Neurology The Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China.
Zhong LuoDepartment of Neurology The Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China.
Xia ZhangDepartment of Neurology The Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China.
Zu-Cai XuDepartment of Neurology The Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China.
Zunyi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is a common neurological disease with various seizure types, complicated etiologies, and unclear mechanisms. Its diagnosis mainly relies on clinical history, but an electroencephalogram is also a crucial auxiliary examination. Recently, brain imaging technology has gained increasing attention in the diagnosis of epilepsy, and conventional magnetic resonance imaging can detect epileptic foci in some patients with epilepsy. However, the results of brain magnetic resonance imaging are normal in some patients. New molecular imaging has gradually developed in recent years and has been applied in the diagnosis of epilepsy, leading to enhanced lesion detection rates. However, the application of these technologies in epilepsy patients with negative brain magnetic resonance must be clarified. Thus, we reviewed the relevant literature and summarized the information to improve the understanding of the molecular imaging application value of epilepsy.

Indexed as

Application valueEpilepsyMolecular imaging

Identifiers

PMID37786793
PMCPMC10528966
OpenAlexW4200553498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.